Home Press Releases Active Pharmaceutical Ingredients CDMO Market to reach USD 155.23 Bn by 2029 at a growth rate of 6.7 percent over the forecast period

Active Pharmaceutical Ingredients CDMO Market to reach USD 155.23 Bn by 2029 at a growth rate of 6.7 percent over the forecast period

by Press Room


(EMAILWIRE.COM, May 06, 2023 ) The total global market for the “Active Pharmaceutical Ingredients CDMO Market” was valued at USD 92.40 Bn in 2021 and is expected to grow at a CAGR of 6.7 percent over the forecast period to reach USD 155.23 Bn by 2029.

Active Pharmaceutical Ingredients CDMO Market Report Scope and Research Methodology

The Active Pharmaceutical Ingredients CDMO Market report provides a qualitative and quantitative analysis of market size, price, demand, mergers and acquisitions, supply chain, investment and expansion plans by key competitors, and predictions. SWOT and PESTLE were used to understand the competitive intensity of the Active Pharmaceutical Ingredients CDMO Market.

Request For Free Sample Report: https://www.maximizemarketresearch.com/request-sample/122726

Active Pharmaceutical Ingredients CDMO Market Dynamics

The Active Pharmaceutical Ingredients CDMO Market is driven by the increasing research and development activities, growth of generic and innovative drugs, growing biopharmaceuticals sectors and cost benefits of CDMO in manufacturing benefits for budding industries.

Active Pharmaceutical Ingredients CDMO Market Regional Insights

Asia pacific dominates the Active Pharmaceutical Ingredients CDMO Market with the largest revenue. The regional market is driven by the increasing development strategies made by various industry, expansion of traditional pharmaceuticals and the rapidly increasing incidence of persistent infections and presence of leading pharmaceutical ingredient providers.

Get a Sample Copy of the Report: https://www.maximizemarketresearch.com/request-sample/122726

Active Pharmaceutical Ingredients CDMO Market Segmentation

By Product Type

Traditional Active Pharmaceutical Ingredient (Traditional API)

Highly Potent Active Pharmaceutical Ingredient (HP-API)

Antibody-Drug Conjugate (ADC)

Other

By Drug

Synthetic

Biotech

By Synthesis

Innovative

Generic

By Workflow

Clinical

Commercial

By Application

Oncology

Hormonal

Glaucoma

Cardiovascular

Diabetes

Other

Active Pharmaceutical Ingredients CDMO Key Players includes:

10x Genomics

Cambrex

Recipharm

Thermo Fisher Pantheon

Corden Pharma

Samsung Biologics

Lonza

Catalent

Siegfried

Piramal Pharma Solutions

Boehringer Ingelheim

catelent Inc.

Recipharm AB

Get the Sample PDF of Report: https://www.maximizemarketresearch.com/request-sample/122726

Maximize Market Research is leading Healthcare research firm, has also published the following reports:

C-reactive Protein Testing Market– The market size is expected to reach USD 1.85 Bn by 2029 at a CAGR of 1.5 percent during the forecast period.

Active Pharmaceutical Ingredients Market– The Market size is expected to reach USD 278.94Bn by 2029 at a CAGR of 6.53 percent during the forecast period.

About Maximize Market Research:

Maximize Market Research provides B2B and 2C research on 6,500 high-growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Défense and other manufacturing sectors.



Source link

You may also like

About Us

Arab Africana™ publishes and aggregates business, socio-economic, Tech and industrial news on Arab countries in Africa.

 

We provide press release distribution to media in Africa including Arab countries, the Arab world and the GCC/MENA regions. To submit a press release for distribution, contact us today.

Trending Now

Newsletter

    ArabAfricana logo-white

    Arab Africana is part of GroupWeb Media Network. ©  2024 GroupWeb Media LLC